☆ACORN CAPITAL ADVISORS, LLC
Quality Q
0.437
AUM ($M)
366
Positions
20
Turnover
0.29
Top-10 wt
90%
Herfindahl
0.118
History (qtrs)
7
Excess Return
—
AI Eval Run AI Eval
Holdings · 23 positions · portfolio value $366M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆CGON funds › | CG ONCOLOGY INC | ADD | — | 21.9% | +0.2% | 80.4 | 1,131,500 | +999 | 6 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | HOLD | — | 16.8% | +8.3% | 61.6 | 1,673,420 | +0 | 6 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | HOLD | — | 10.9% | +3.6% | 40.0 | 2,144,844 | +0 | 6 | — |
| ☆CADL funds › | CANDEL THERAPEUTICS INC | HOLD | — | 9.8% | +4.9% | 36.0 | 3,497,948 | +0 | 6 | — |
| ☆CUSIP:74587V107 funds › | PUMA BIOTECHNOLOGY INC | HOLD | — | 9.1% | +1.6% | 33.5 | 4,131,299 | +0 | 6 | — |
| ☆JBIO funds › | JADE BIOSCEINCES INC | ADD | — | 6.0% | +2.8% | 21.9 | 986,760 | +200,000 | 2 | — |
| ☆BCAX funds › | BICARA THERAPEUTICS | TRIM | — | 5.2% | +1.6% | 19.1 | 643,381 | -1 | 6 | — |
| ☆KPTI funds › | KARYOPHARM THERAPEUTICS INC | ADD | — | 4.0% | +3.6% | 14.8 | 1,518,113 | +1,230,287 | 2 | — |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | HOLD | — | 3.5% | +0.2% | 12.9 | 2,839,674 | +0 | 6 | — |
| ☆HELP funds › | HELUS PHARMA INC. | HOLD | — | 2.8% | +0.7% | 10.2 | 1,540,266 | +0 | 6 | — |
| ☆TARA funds › | PROTARA THERAPEUTICS INC | HOLD | — | 1.8% | -0.8% | 6.7 | 1,752,115 | +0 | 6 | — |
| ☆AURA funds › | AURA BIOSCIENCES INC | ADD | — | 1.8% | +0.7% | 6.6 | 929,077 | +333,333 | 6 | — |
| ☆LONA funds › | LEONABIO, INC. | HOLD | — | 1.6% | -0.3% | 5.8 | 634,539 | +0 | 3 | — |
| ☆VSTM funds › | VERASTEM INC | HOLD | — | 1.5% | -0.7% | 5.6 | 1,469,153 | +0 | 6 | — |
| ☆WHWK funds › | WHITEHAWK THERAPEUTICS INC | HOLD | Common Stock | 1.4% | +0.3% | 5.2 | 1,139,363 | +0 | 6 | — |
| ☆QTTB funds › | Q32 BIO INC. | TRIM | — | 0.8% | +0.2% | 2.8 | 216,171 | -98,881 | 6 | — |
| ☆ENGN funds › | EUGENE THERAPEUTICS | NEW | — | 0.6% | +0.6% | 2.2 | 1,271,257 | +1,271,257 | 1 | — |
| ☆JSPR funds › | JASPER THERAPEUTICS | ADD | — | 0.2% | -0.2% | 0.6 | 1,438,159 | +26,667 | 4 | — |
| ☆CUSIP:09077B104 funds › | BIOATLA INC | TRIM | — | 0.1% | -0.1% | 0.4 | 108,126 | -5,298,219 | 6 | — |
| ☆VYNE funds › | VYNE THERAPEUTICS INC | HOLD | — | 0.0% | +0.0% | 0.0 | 1,425 | +0 | 6 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -26.2% | 0.0 | 0 | -1,746,264 | 0 | — |
| ☆CUSIP:98420X103 funds › | X4 PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -234,039 | 0 | — |
| ☆CRDF funds › | CARDIF ONCOLOGY INC | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -1,762,084 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 366 | 20 | 0.29 | 90% | 0.118 | 0.438 | — | in |
| 2026Q1 | 352 | 22 | 0.13 | 89% | 0.142 | 0.749 | — | in |
| 2025Q4 | 295 | 21 | 0.20 | 89% | 0.121 | 0.542 | — | in |
| 2025Q3 | 197 | 20 | 0.18 | 88% | 0.111 | 0.523 | — | in |
| 2025Q2 | 153 | 21 | 0.09 | 83% | 0.093 | 0.659 | — | in |
| 2025Q1 | 144 | 22 | 0.15 | 84% | 0.094 | 0.549 | — | entered |
| 2024Q4 | 190 | 21 | 0.00 | 77% | 0.080 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status